All terms in GO
| Label | Id | Description |
|---|---|---|
| beta-zeacarotene catabolic process | GO_1901817 | [The chemical reactions and pathways resulting in the breakdown of beta-zeacarotene.] |
| beta-zeacarotene biosynthetic process | GO_1901818 | [The chemical reactions and pathways resulting in the formation of beta-zeacarotene.] |
| negative regulation of transcription regulatory region DNA binding | GO_2000678 | [Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.] |
| negative regulation of DNA binding | GO_0043392 | [Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).] |
| positive regulation of transcription regulatory region DNA binding | GO_2000679 | [Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.] |
| positive regulation of DNA binding | GO_0043388 | [Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).] |
| positive regulation of type B pancreatic cell apoptotic process | GO_2000676 | [Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process.] |
| regulation of DNA binding | GO_0051101 | [Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).] |
| negative regulation of myoblast fusion | GO_1901740 | [Any process that stops, prevents or reduces the frequency, rate or extent of myoblast fusion.] |
| regulation of myoblast fusion | GO_1901739 | [Any process that modulates the frequency, rate or extent of myoblast fusion.] |
| regulation of early endosome to late endosome transport | GO_2000641 | [Any process that modulates the frequency, rate or extent of early endosome to late endosome transport.] |
| regulation of cytoplasmic transport | GO_1903649 | [Any process that modulates the frequency, rate or extent of cytoplasmic transport.] |
| early endosome to late endosome transport | GO_0045022 | [The directed movement of substances, in membrane-bounded vesicles, from the early sorting endosomes to the late sorting endosomes; transport occurs along microtubules and can be experimentally blocked with microtubule-depolymerizing drugs.] |
| positive regulation of myoblast fusion | GO_1901741 | [Any process that activates or increases the frequency, rate or extent of myoblast fusion.] |
| negative regulation of early endosome to late endosome transport | GO_2000642 | [Any process that stops, prevents or reduces the frequency, rate or extent of early endosome to late endosome transport.] |
| negative regulation of cytoplasmic transport | GO_1903650 | [Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic transport.] |
| 2-deoxystreptamine metabolic process | GO_1901742 | [The chemical reactions and pathways involving 2-deoxystreptamine.] |
| 2-deoxystreptamine catabolic process | GO_1901743 | [The chemical reactions and pathways resulting in the breakdown of 2-deoxystreptamine.] |
| SREBP signaling pathway | GO_0032933 | [A series of molecular signals from the endoplasmic reticulum to the nucleus generated as a consequence of decreased levels of one or more sterols (and in some yeast, changes in oxygen levels) and which proceeds through activation of a sterol response element binding transcription factor (SREBP) to result in up-regulation of target gene transcription.] |
| 2-deoxystreptamine biosynthetic process | GO_1901744 | [The chemical reactions and pathways resulting in the formation of 2-deoxystreptamine.] |